AU4015897A – N-substututed indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action
– Google Patents
AU4015897A – N-substututed indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action
– Google Patents
N-substututed indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action
Info
Publication number
AU4015897A
AU4015897A
AU40158/97A
AU4015897A
AU4015897A
AU 4015897 A
AU4015897 A
AU 4015897A
AU 40158/97 A
AU40158/97 A
AU 40158/97A
AU 4015897 A
AU4015897 A
AU 4015897A
AU 4015897 A
AU4015897 A
AU 4015897A
Authority
AU
Australia
Prior art keywords
glyoxylamides
substututed
asthmatic
antiallergic
immunosuppressant
Prior art date
1996-09-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU40158/97A
Other versions
AU726521C
(en
AU726521B2
(en
Inventor
Kay Brune
Peter Emig
Bernhard Kutscher
Guillaume Le Baut
Cecilia Menciu
Stefan Szelenyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ziopharm Oncology Inc
Original Assignee
Ziopharm Oncology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1996-09-06
Filing date
1997-08-16
Publication date
1998-03-26
1997-08-16
Application filed by Ziopharm Oncology Inc
filed
Critical
Ziopharm Oncology Inc
1998-03-26
Publication of AU4015897A
publication
Critical
patent/AU4015897A/en
1998-03-26
Publication of AU726521C
publication
Critical
patent/AU726521C/en
2000-11-09
Application granted
granted
Critical
2000-11-09
Publication of AU726521B2
publication
Critical
patent/AU726521B2/en
2007-10-04
Assigned to ZIOPHARM ONCOLOGY, INC.
reassignment
ZIOPHARM ONCOLOGY, INC.
Alteration of Name(s) in Register under S187
Assignors: ASTA MEDICA AKTIENGESELLSCHAFT
2017-08-16
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P11/00—Drugs for disorders of the respiratory system
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P11/00—Drugs for disorders of the respiratory system
A61P11/06—Antiasthmatics
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P17/00—Drugs for dermatological disorders
A61P17/06—Antipsoriatics
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P19/00—Drugs for skeletal disorders
A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P37/00—Drugs for immunological or allergic disorders
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P37/00—Drugs for immunological or allergic disorders
A61P37/02—Immunomodulators
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P37/00—Drugs for immunological or allergic disorders
A61P37/02—Immunomodulators
A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P37/00—Drugs for immunological or allergic disorders
A61P37/08—Antiallergic agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
C07D209/04—Indoles; Hydrogenated indoles
C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
AU40158/97A
1996-09-06
1997-08-16
N-substututed indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action
Ceased
AU726521B2
(en)
Applications Claiming Priority (3)
Application Number
Priority Date
Filing Date
Title
DE19636150A
DE19636150A1
(en)
1996-09-06
1996-09-06
N-substituted indole-3-glyoxylamides with antiasthmatic, antiallergic and immunosuppressive / immunomodulating effects
DE19636150
1996-09-06
PCT/EP1997/004474
WO1998009946A1
(en)
1996-09-06
1997-08-16
N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect
Publications (3)
Publication Number
Publication Date
AU4015897A
true
AU4015897A
(en)
1998-03-26
AU726521C
AU726521C
(en)
1998-03-26
AU726521B2
AU726521B2
(en)
2000-11-09
Family
ID=7804772
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU40158/97A
Ceased
AU726521B2
(en)
1996-09-06
1997-08-16
N-substututed indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action
Country Status (27)
Country
Link
US
(4)
US6008231A
(en)
EP
(1)
EP0931063B3
(en)
JP
(1)
JP3296437B2
(en)
KR
(1)
KR100516321B1
(en)
CN
(3)
CN100488948C
(en)
AR
(1)
AR008630A1
(en)
AT
(1)
ATE342889T1
(en)
AU
(1)
AU726521B2
(en)
BR
(1)
BR9712808B1
(en)
CA
(1)
CA2215013C
(en)
CZ
(1)
CZ302301B6
(en)
DE
(2)
DE19636150A1
(en)
DK
(1)
DK0931063T5
(en)
ES
(1)
ES2276433T7
(en)
HK
(3)
HK1021641A1
(en)
HU
(1)
HU227797B1
(en)
IL
(1)
IL127798A
(en)
NO
(2)
NO314725B3
(en)
NZ
(1)
NZ334476A
(en)
PT
(1)
PT931063E
(en)
RU
(1)
RU2237661C2
(en)
SK
(1)
SK285618B6
(en)
TR
(1)
TR199900469T2
(en)
TW
(1)
TW550256B
(en)
UA
(1)
UA60312C2
(en)
WO
(1)
WO1998009946A1
(en)
ZA
(1)
ZA977475B
(en)
Cited By (2)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU748403B2
(en)
*
1998-04-28
2002-06-06
Elbion Ag
New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same
AU768510B2
(en)
*
1998-04-02
2003-12-18
Ziopharm Oncology, Inc.
Indolyl-3-glyoxylic acid derivatives with antitumoral activity
Families Citing this family (47)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
DE19636150A1
(en)
*
1996-09-06
1998-03-12
Asta Medica Ag
N-substituted indole-3-glyoxylamides with antiasthmatic, antiallergic and immunosuppressive / immunomodulating effects
AU774929B2
(en)
*
1998-03-31
2004-07-15
Institutes For Pharmaceutical Discovery, Llc, The
Substituted indolealkanoic acids
CZ302588B6
(en)
*
1998-04-02
2011-07-27
Ziopharm Oncology, Inc.
Use of N-substituted indole-3-gloxylamide for preparing a medicament
DE19946301A1
(en)
1998-04-02
2001-04-19
Asta Medica Ag
Antitumor agents and angiogenesis inhibitors having low neurotoxicity, comprise indole-3-glyoxylamide derivatives, are effective against resistant and metastasis-forming carcinomas
DE19917504A1
(en)
*
1999-04-17
2000-10-19
Dresden Arzneimittel
New hydroxy-indole derivatives, useful in treatment of degenerative joint disease, viral and parasitic infections, bronchial, dermatological, neurodegenerative and prostate disorders, etc.
DE19818964A1
(en)
*
1998-04-28
1999-11-04
Dresden Arzneimittel
New hydroxy-indole derivatives useful in treatment of degenerative joint disease, viral and parasitic infections, bronchial, dermatological, neurodegenerative and prostate disorders, etc.
AU777012B2
(en)
1999-08-21
2004-09-30
Takeda Gmbh
Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonist
TWI269654B
(en)
*
1999-09-28
2007-01-01
Baxter Healthcare Sa
N-substituted indole-3-glyoxylamide compounds having anti-tumor action
DE19962300A1
(en)
*
1999-12-23
2001-06-28
Asta Medica Ag
New N-benzylindolyl glyoxylic acid derivatives are useful as antitumor agents
DE10022925A1
(en)
*
2000-05-11
2001-11-15
Basf Ag
New indole-carboxamide or azepino-indole derivatives and analogs, are poly-ADP ribose polymerase inhibitors useful e.g. for treating neurodegenerative disease, ischemia, epilepsy, tumors, sepsis or diabetes mellitus
DE10037310A1
(en)
2000-07-28
2002-02-07
Asta Medica Ag
New indole derivatives and their use as medicines
AU2002323474B2
(en)
*
2001-09-13
2006-10-05
Synta Pharmaceuticals Corp
3-glyoxlylamideindoles for treating cancer
US6903104B2
(en)
*
2001-12-06
2005-06-07
National Health Research Institutes
Indol-3-YL-2-oxoacetamide compounds and methods of use thereof
CA2493755A1
(en)
*
2002-07-26
2004-02-05
The Institutes For Pharmaceutical Discovery, Llc
Substituted indolealkanoic acids derivative and formulations containing same for use in treatment of diabetic complications
NZ537947A
(en)
*
2002-08-01
2006-11-30
Elbion Ag
Method for producing highly pure hydroxy indolyl glyoxylic acid amides
DE10253426B4
(en)
*
2002-11-15
2005-09-22
Elbion Ag
Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and methods for their preparation
DE10318610A1
(en)
*
2003-04-24
2004-11-11
Elbion Ag
7-azaindoles and their use as therapeutic agents
DE10318609A1
(en)
*
2003-04-24
2004-11-11
Elbion Ag
5-hydroxyindoles with N-oxide groups and their use as therapeutic agents
DE10318611A1
(en)
2003-04-24
2004-11-11
Elbion Ag
4-, 6- or 7-hydroxyindoles with N-oxide groups and their use as therapeutic agents
US20050075364A1
(en)
*
2003-07-01
2005-04-07
Kap-Sun Yeung
Indole, azaindole and related heterocyclic N-substituted piperazine derivatives
CA2538820A1
(en)
2003-09-11
2005-03-17
Kemia, Inc.
Cytokine inhibitors
EP2583678A3
(en)
2004-06-24
2013-11-13
Novartis Vaccines and Diagnostics, Inc.
Small molecule immunopotentiators and assays for their detection
DE102004031538A1
(en)
*
2004-06-29
2006-02-09
Baxter International Inc., Deerfield
Presentation form (obtainable by dissolving indibulin in or with a highly concentrated organic acid), useful to orally administer poorly soluble active compound indibulin, comprises a poorly soluble active compound indibulin
ES2424255T3
(en)
*
2004-11-08
2013-09-30
Baxter International Inc.
Particulate compositions of tubulin inhibitors
US20060100432A1
(en)
*
2004-11-09
2006-05-11
Matiskella John D
Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US20060100209A1
(en)
*
2004-11-09
2006-05-11
Chong-Hui Gu
Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US8604055B2
(en)
2004-12-31
2013-12-10
Dr. Reddy’s Laboratories Ltd.
Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
JP5096927B2
(en)
2004-12-31
2012-12-12
レディ ユーエス セラピューティックス， インコーポレイテッド
Novel benzylamine derivatives as CETP inhibitors
JP2006247963A
(en)
*
2005-03-09
2006-09-21
Oji Paper Co Ltd
Inkjet recording sheet
WO2006099256A2
(en)
*
2005-03-11
2006-09-21
Vertex Pharmaceuticals Incorporated
Modulators of atp-binding cassette transporters
US7328672B2
(en)
2005-04-29
2008-02-12
Tendik Development, Llc
Radial impulse engine, pump, and compressor systems, and associated methods of operation
US20060280787A1
(en)
*
2005-06-14
2006-12-14
Baxter International Inc.
Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
US7598380B2
(en)
*
2005-08-03
2009-10-06
Bristol-Myers Squibb Company
Method of preparation of azaindole derivatives
ITMI20051999A1
(en)
*
2005-10-21
2007-04-22
Eratech S R L
INHALATION FORMULATIONS OF DRUGS IN DRY POWDER FOR ADMINISTRATION AS SUCH OR WITH NEBULIZER AND EQUIPPED WITH HIGH EROGABILITY RESPIRABILITY AND STABILITY
US7851476B2
(en)
*
2005-12-14
2010-12-14
Bristol-Myers Squibb Company
Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2
(en)
2006-04-25
2010-10-05
Bristol-Myers Squibb Company
Diketo-piperazine and piperidine derivatives as antiviral agents
EA021461B1
(en)
2006-07-05
2015-06-30
Такеда Гмбх
Pharmaceutical composition and combination pharmaceutical containing hmg-coa reductase and phosphodiesterase 4 inhibitors and use thereof for the treatment of inflammatory pulmonary diseases
EP2610244A1
(en)
*
2006-08-07
2013-07-03
Ironwood Pharmaceuticals, Inc.
Indole compounds
JP2010509237A
(en)
*
2006-11-02
2010-03-25
アレテ セラピューティクス， インコーポレイテッド
Soluble epoxide hydrolase inhibitor
AU2007325797B2
(en)
*
2006-11-28
2014-03-13
Ziopharm Oncology, Inc.
Use of indolyl-3-glyoxylic acid derivatives including indibulin, alone or in combination with further agents for treating cancer
EP3791880A1
(en)
2009-04-29
2021-03-17
Amarin Pharmaceuticals Ireland Limited
Pharmaceutical compositions comprising epa
AR084433A1
(en)
2010-12-22
2013-05-15
Ironwood Pharmaceuticals Inc
FAAH INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JP5964965B2
(en)
2011-08-18
2016-08-03
ドクター レディズ ラボラトリーズ リミテッド
Substituted heterocyclic amine compounds as cholesteryl ester transfer protein (CETP) inhibitors
WO2013046045A1
(en)
2011-09-27
2013-04-04
Dr. Reddy’s Laboratories, Ltd.
5 – benzylaminomethyl – 6 – aminopyrazolo [3, 4 -b] pyridine derivatives as cholesteryl ester -transfer protein (cetp) inhibitors useful for the treatment of atherosclerosis
EP3165224A1
(en)
2015-11-09
2017-05-10
Albert-Ludwigs-Universität Freiburg
Use of pde4 inhibitors for the prophylaxis and/or therapy of dyslipoproteinaemia and related disorders
WO2017089347A1
(en)
2015-11-25
2017-06-01
Inserm (Institut National De La Sante Et De La Recherche Medicale)
Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
CN109000634B
(en)
*
2018-06-04
2022-06-03
上海智蕙林医疗科技有限公司
Navigation object traveling route reminding method and system
Family Cites Families (10)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
GB797258A
(en)
*
1955-04-11
1958-06-25
Upjohn Co
3-substituted indoles
GB944443A
(en)
*
1959-09-25
1900-01-01
GB1028812A
(en)
*
1962-08-28
1966-05-11
Ici Ltd
Indole derivatives
GB1089071A
(en)
*
1964-02-28
1967-11-01
Merck & Co Inc
Indole derivatives
US3686213A
(en)
*
1970-08-28
1972-08-22
American Cyanamid Co
Substituted aminoethyl indoles
FR2689888B1
(en)
*
1992-04-10
1994-06-10
Rhone Poulenc Rorer Sa
NOVEL PERHYDROISOINDOLE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
IL113210A
(en)
*
1994-04-01
2001-01-28
Lilly Co Eli
1H-indole-3- glyoxylamide spla2 inhibitors and pharmaceutical compositions containing them
DE19636150A1
(en)
*
1996-09-06
1998-03-12
Asta Medica Ag
N-substituted indole-3-glyoxylamides with antiasthmatic, antiallergic and immunosuppressive / immunomodulating effects
DE19946301A1
(en)
*
1998-04-02
2001-04-19
Asta Medica Ag
Antitumor agents and angiogenesis inhibitors having low neurotoxicity, comprise indole-3-glyoxylamide derivatives, are effective against resistant and metastasis-forming carcinomas
US7205299B2
(en)
*
2003-06-05
2007-04-17
Zentaris Gmbh
Indole derivatives having an apoptosis-inducing effect
1996
1996-09-06
DE
DE19636150A
patent/DE19636150A1/en
not_active
Ceased
1997
1997-08-16
PT
PT97937586T
patent/PT931063E/en
unknown
1997-08-16
CN
CNB021320616A
patent/CN100488948C/en
not_active
Expired – Fee Related
1997-08-16
CN
CN2008100087226A
patent/CN101219985B/en
not_active
Expired – Fee Related
1997-08-16
BR
BRPI9712808-2A
patent/BR9712808B1/en
not_active
IP Right Cessation
1997-08-16
DE
DE59712752T
patent/DE59712752D1/en
not_active
Expired – Lifetime
1997-08-16
UA
UA99041907A
patent/UA60312C2/en
unknown
1997-08-16
TR
TR1999/00469T
patent/TR199900469T2/en
unknown
1997-08-16
WO
PCT/EP1997/004474
patent/WO1998009946A1/en
active
IP Right Grant
1997-08-16
DK
DK97937586T
patent/DK0931063T5/en
active
1997-08-16
EP
EP97937586A
patent/EP0931063B3/en
not_active
Expired – Lifetime
1997-08-16
AT
AT97937586T
patent/ATE342889T1/en
active
1997-08-16
KR
KR10-1999-7001909A
patent/KR100516321B1/en
not_active
IP Right Cessation
1997-08-16
JP
JP51216798A
patent/JP3296437B2/en
not_active
Expired – Fee Related
1997-08-16
AU
AU40158/97A
patent/AU726521B2/en
not_active
Ceased
1997-08-16
SK
SK271-99A
patent/SK285618B6/en
not_active
IP Right Cessation
1997-08-16
IL
IL12779897A
patent/IL127798A/en
not_active
IP Right Cessation
1997-08-16
NZ
NZ334476A
patent/NZ334476A/en
not_active
IP Right Cessation
1997-08-16
RU
RU99106782A
patent/RU2237661C2/en
not_active
IP Right Cessation
1997-08-16
CZ
CZ0061699A
patent/CZ302301B6/en
not_active
IP Right Cessation
1997-08-16
HU
HU9903741A
patent/HU227797B1/en
not_active
IP Right Cessation
1997-08-16
ES
ES97937586T
patent/ES2276433T7/en
active
Active
1997-08-16
CN
CNB971971285A
patent/CN100376554C/en
not_active
Expired – Fee Related
1997-08-20
ZA
ZA9707475A
patent/ZA977475B/en
unknown
1997-09-04
CA
CA002215013A
patent/CA2215013C/en
not_active
Expired – Fee Related
1997-09-05
AR
ARP970104064A
patent/AR008630A1/en
active
IP Right Grant
1997-09-08
US
US08/925,326
patent/US6008231A/en
not_active
Expired – Lifetime
1997-09-30
TW
TW086112985A
patent/TW550256B/en
not_active
IP Right Cessation
1999
1999-03-04
NO
NO19991071A
patent/NO314725B3/en
not_active
IP Right Cessation
1999-09-30
US
US09/409,263
patent/US6344467B1/en
not_active
Expired – Lifetime
2000
2000-02-02
HK
HK00100629A
patent/HK1021641A1/en
not_active
IP Right Cessation
2002
2002-01-30
US
US10/058,836
patent/US20020161025A1/en
not_active
Abandoned
2003
2003-01-30
NO
NO20030481A
patent/NO20030481D0/en
not_active
Application Discontinuation
2003-04-01
US
US10/402,931
patent/US6919344B2/en
not_active
Expired – Fee Related
2004
2004-09-17
HK
HK04107115.1A
patent/HK1064379A1/en
not_active
IP Right Cessation
2009
2009-01-15
HK
HK09100395.2A
patent/HK1123280A1/en
not_active
IP Right Cessation
Cited By (2)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU768510B2
(en)
*
1998-04-02
2003-12-18
Ziopharm Oncology, Inc.
Indolyl-3-glyoxylic acid derivatives with antitumoral activity
AU748403B2
(en)
*
1998-04-28
2002-06-06
Elbion Ag
New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same
Also Published As
Publication number
Publication date
JP3296437B2
(en)
2002-07-02
UA60312C2
(en)
2003-10-15
RU2237661C2
(en)
2004-10-10
HK1123280A1
(en)
2009-06-12
US6919344B2
(en)
2005-07-19
ZA977475B
(en)
1998-02-19
IL127798A0
(en)
1999-10-28
NO991071D0
(en)
1999-03-04
HU9903741A3
(en)
2001-01-29
NO991071L
(en)
1999-03-04
ES2276433T3
(en)
2007-06-16
EP0931063B1
(en)
2006-10-18
WO1998009946A1
(en)
1998-03-12
HK1064379A1
(en)
2005-01-28
CN101219985B
(en)
2011-04-27
TR199900469T2
(en)
1999-05-21
NO314725B1
(en)
2003-05-12
NZ334476A
(en)
2000-05-26
CN1227542A
(en)
1999-09-01
BR9712808A
(en)
1999-11-23
ATE342889T1
(en)
2006-11-15
US20030207892A1
(en)
2003-11-06
HK1021641A1
(en)
2000-06-23
AU726521C
(en)
1998-03-26
CN100376554C
(en)
2008-03-26
IL127798A
(en)
2003-07-31
NO314725B3
(en)
2009-03-09
PT931063E
(en)
2007-02-28
CZ61699A3
(en)
1999-06-16
CA2215013C
(en)
2002-03-05
DE19636150A1
(en)
1998-03-12
HU9903741A2
(en)
2000-04-28
CN1496980A
(en)
2004-05-19
DE59712752D1
(en)
2006-11-30
KR20000068495A
(en)
2000-11-25
ES2276433T7
(en)
2009-11-05
CA2215013A1
(en)
1998-03-06
HU227797B1
(en)
2012-03-28
AU726521B2
(en)
2000-11-09
NO20030481L
(en)
1999-03-04
TW550256B
(en)
2003-09-01
DK0931063T3
(en)
2007-02-19
BR9712808B1
(en)
2009-05-05
CN101219985A
(en)
2008-07-16
AR008630A1
(en)
2000-02-09
NO20030481D0
(en)
2003-01-30
SK27199A3
(en)
1999-08-06
SK285618B6
(en)
2007-05-03
US20020161025A1
(en)
2002-10-31
EP0931063B3
(en)
2009-04-08
CN100488948C
(en)
2009-05-20
EP0931063A1
(en)
1999-07-28
KR100516321B1
(en)
2005-09-23
DK0931063T5
(en)
2010-01-11
US6344467B1
(en)
2002-02-05
US6008231A
(en)
1999-12-28
JP2000505098A
(en)
2000-04-25
CZ302301B6
(en)
2011-02-09
Similar Documents
Publication
Publication Date
Title
AU726521C
(en)
1998-03-26
N-substututed indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action
AU2440997A
(en)
1997-10-29
Calixpyrroles, calixpyridinopyrroles and calixpyridines
AU3879197A
(en)
1998-02-02
Extensible indexing
AU2303097A
(en)
1997-11-07
Quinazoline derivatives
AU1559897A
(en)
1997-08-20
Bumper, and the fabrication thereof
AUPP021697A0
(en)
1997-11-27
Radio detonation system
AU4565197A
(en)
1998-04-24
Colostrinin, and uses thereof
AU1609597A
(en)
1997-08-28
Antenna arrangement
AU4585397A
(en)
1998-04-24
Bearing having micropores, and design method thereof
AU3324397A
(en)
1998-02-12
Adjustable interconnected lock
AU1475897A
(en)
1997-10-30
Cellular structure
AU4493897A
(en)
1998-04-17
Organometallic-metabolizing yeast
AU7104398A
(en)
1998-12-08
Conopeptides auia, auib and auic
AU3809897A
(en)
1998-02-25
Ectoparasite histamine releasing factor, genes and uses thereof
AU3409297A
(en)
1998-01-14
Polyfunctional crosslinking acylimidazolidinone derivatives
AU1726695A
(en)
1996-07-31
Turcasarins, novel expanded porphyrins, and uses thereof
AU7582996A
(en)
1997-09-22
Antenna arrangement
AU4108897A
(en)
1998-04-02
Cup-holder
AU5557698A
(en)
1998-06-29
Novel calpaines, their preparation and use
AU1621697A
(en)
1997-09-18
UV absorbers, their preparation and use
AU6936296A
(en)
1998-04-02
Locking arrangement
AU1906599A
(en)
1999-06-28
Pancreatic-derived factors, and uses related thereto
AU5411098A
(en)
1998-07-15
Polyurethane
AU3199497A
(en)
1998-01-05
Antenna arrangement
AUPO440496A0
(en)
1997-01-23
Quinazoline derivatives
Legal Events
Date
Code
Title
Description
2001-03-08
FGA
Letters patent sealed or granted (standard patent)
